Sipai Health Technology Co (HKSE:00314) EV-to-EBIT : -13.22 (As of May. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sipai Health Technology Co's Enterprise Value is HK$3,501 Mil. Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-265 Mil. Therefore, Sipai Health Technology Co's EV-to-EBIT for today is -13.22.

The historical rank and industry rank for Sipai Health Technology Co's EV-to-EBIT or its related term are showing as below:

HKSE:00314' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.12 Med: -0.55 Max: 0.67
Current: -12.44

During the past 3 years, the highest EV-to-EBIT of Sipai Health Technology Co was 0.67. The lowest was -15.12. And the median was -0.55.

HKSE:00314's EV-to-EBIT is ranked worse than
100% of 81 companies
in the Medical Distribution industry
Industry Median: 12.74 vs HKSE:00314: -12.44

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sipai Health Technology Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$4,106 Mil. Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-265 Mil. Sipai Health Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -6.45%.

Sipai Health Technology Co EV-to-EBIT Historical Data

The historical data trend for Sipai Health Technology Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co EV-to-EBIT Chart

Sipai Health Technology Co Annual Data

Trend

Dec21

Dec22

Dec23

EV-to-EBIT

-8.28

-15.50

Sipai Health Technology Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	-	-	-8.28	-	-15.50

Competitive Comparison of Sipai Health Technology Co's EV-to-EBIT

For the Medical Distribution subindustry, Sipai Health Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sipai Health Technology Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's EV-to-EBIT falls into.

Sipai Health Technology Co EV-to-EBIT Calculation

Sipai Health Technology Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	3501.163	/	-264.889
	=	-13.22

Sipai Health Technology Co's current Enterprise Value is HK$3,501 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-265 Mil.

Sipai Health Technology Co (HKSE:00314) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sipai Health Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-264.889	/	4106.125
	=	-6.45 %

Sipai Health Technology Co's Enterprise Value for the quarter that ended in Dec. 2023 was HK$4,106 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-265 Mil.

Sipai Health Technology Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sipai Health Technology Co (HKSE:00314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

AX1:Germany

Address

No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN

Website

https://www.medbankshealthtech.com

Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Executives

Chang Jimmy Ching-hsin	2201 Interest of corporation controlled by you
Jeneration Group Limited	2201 Interest of corporation controlled by you
Leung Catherine Ho Yan	2202 Interest of your spouse
Purple Panther	2201 Interest of corporation controlled by you
Ma Xuguang	2501 Other
Li Ji	2501 Other
Wise Approach Investments Limited	2101 Beneficial owner
Ark Trust (hong Kong) Limited	2301 Trustee
Jpmorgan Chase & Co.	2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd.	2101 Beneficial owner
Simul International Holdings Limited	2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines